Sangamo Therapeutics(SGMO)

泼天财富我自来07-26 10:27

$Sangamo Therapeutics(SGMO)$ 补充更新一下
2024/7/24 该公司公布和辉瑞合作开发血友病基因药物三期达标，股价暴涨，后续可期！查看全文

产业链观察07-24 21:24

#药闻简讯# 2024 年 7 月 24 日，$辉瑞(PFE)$ 今天宣布了评估giroctocogene fitelparvovec的3期研究（NCT04370054）的积极顶线结果，该研究是一种用于治疗中度至重度血友病A成人的研究性基因疗法。$Sangamo Therapeutics(SGMO)$查看全文

当期报告

Sangamo Therapeutics(SGMO)2023-11-04 04:05

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-23-036697  Act: 34  Size: 1 MB 网页链接查看全文

员工持股计划

Sangamo Therapeutics(SGMO)2023-08-09 04:55

$Sangamo Therapeutics(SGMO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-206301  Act: 33  Size: 73 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047586  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047590  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001756  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001754  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001755  Size: 6 KB 网页链接查看全文

其他

Sangamo Therapeutics(SGMO)04-20 04:25

$Sangamo Therapeutics(SGMO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102893  Act: 34  Size: 17 MB 网页链接查看全文

薛定锷之猫2017-04-01 07:48

$Sangamo Biosciences (SGMO)$ BB持仓4.1m查看全文

卖飞光荣亏损可耻2015-09-11 21:02

$Sangamo Biosciences (SGMO)$查看全文

zz144262015-08-12 00:18

$Sangamo Biosciences (SGMO)$ 查看全文

annajiang2015-08-01 01:34

我刚刚关注了 $Sangamo Biosciences (SGMO)$ ，当前价 9.11 。查看全文

超级大坏蛋12015-08-01 00:02

$Sangamo Biosciences (SGMO)$ 这个差不多了。查看全文

美国最佳生药对冲基金掌门人心水选择

美股基金策略2015-07-07 21:40

$Sangamo Biosciences (SGMO)$ $TG THERAPEUTICS INC(TGTX)$ $Ardelyx(ARDX)$ $Dyax(DYAX)$ $爱克莱恩(ACHN)$ $Tekmira Pharmaceuticals Corp(TKMR)$ $Coherus BioSciences(CHRS)$
Peter Kolchinsky，美国RA医疗资本创始人，专注于生物制药领域二级市场和一级市场投资。在4岁的时候，Kolchins...查看全文

Lilywang10122015-06-04 04:21

$Sangamo Biosciences (SGMO)$ 盘后1股，一股低卖，压低价钱查看全文

Lilywang10122015-06-04 02:10

$Sangamo Biosciences (SGMO)$ 最近喜欢埋伏，埋伏的一般不亏都是挣的查看全文

Lilywang10122015-06-03 11:18

$Sangamo Biosciences (SGMO)$ 盘后有人入了30万股，横盘2个星期,可以关注查看全文

Kevinsnap2015-04-27 23:47

$Sangamo Biosciences (SGMO)$ 可以入仓了。查看全文

上行空间均超50%，RBC力荐这三只潜力股

智通财经APP获悉，近期，RBC针对Verrica Pharmaceuticals(VRCA.US)、Sangamo Therapeutics(SGMO.US)、GooseHead Insurance(GSHD.US)三家公司发表研报，并强调了这三只股票未来强劲的长期增长前景，预计在未来一年的上行空间将至少达到50... 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-24-032815  Act: 34  Size: 287 KB 网页链接

超过5%股东持股披露「修订」

$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008122  Act: 34  Size: 12 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016686  Size: 6 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015752  Size: 8 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015753  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015754  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015755  Size: 8 KB 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001628280-24-026903  Act: 34  Size: 13 MB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014796  Size: 9 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014798  Size: 9 KB 网页链接